Management of Insomnia in Chronic Lung Diseases

被引:0
|
作者
Ascher, Kori [1 ]
Abreu, Alexandre R. [1 ]
Chediak, Alejandro D. [1 ]
机构
[1] Univ Miami, Dept Med, Leonard M Miller Sch Med, Div Pulm Allergy Crit Care & Sleep Med, Miami, FL 33136 USA
关键词
Insomnia; Treatment; Sleep apnea; Lung disease; Pulmonary; OBSTRUCTIVE SLEEP-APNEA; COGNITIVE-BEHAVIORAL THERAPY; VENTILATORY RESPONSE; DOUBLE-BLIND; RESPIRATION; PRESSURE; MODERATE; SUVOREXANT; RAMELTEON; EFFICACY;
D O I
10.1007/s13665-020-00253-z
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Purpose of Review Review the treatment of insomnia in those with chronic lung diseases. Recent Findings Cognitive behavioral therapy for insomnia and positive airway pressure, the latter for those with sleep disordered breathing, are effective and safe alternatives to hypnotic therapy. Some new hypnotics improve sleep via mechanisms that theoretically render them safe to use in those afflicted with both insomnia and chronic lung disease. Treatment for insomnia may include cognitive behavioral therapy, positive airway pressure, and pharmacotherapy. Computerized cognitive behavioral therapy is a safe and effective treatment alternative for insomnia. Insomnia comorbid with obstructive sleep apnea can respond favorably to positive airway pressure therapy. Prescription hypnotics that affect sleep via modulation of melatonin, histamine, and orexin pathways are theoretically well suited for treatment of insomnia in those with chronic lung diseases. We offer the reader an algorithm to manage a patient with insomnia and chronic lung disease.
引用
收藏
页码:102 / 109
页数:8
相关论文
共 50 条
  • [31] Probiotics in the Management of Lung Diseases
    Mortaz, Esmaeil
    Adcock, Ian. M.
    Folkerts, Gert
    Barnes, Peter J.
    Vos, Arjan Paul
    Garssen, Johan
    MEDIATORS OF INFLAMMATION, 2013, 2013
  • [32] Perspectives on the management of insomnia in patients with chronic respiratory disorders
    George, CFP
    SLEEP, 2000, 23 : S31 - S35
  • [33] Management of Insomnia in Patients With Chronic Obstructive Pulmonary Disease
    Charles F.P. George
    Charles D. Bayliff
    Drugs, 2003, 63 : 379 - 387
  • [34] Delphi consensus recommendations for the management of chronic insomnia in Canada
    Morin, Charles M.
    Khullar, Atul
    Robillard, Rebecca
    Desautels, Alex
    Mak, Michael S. B.
    Dang-Vu, Thien Thanh
    Chow, Walter
    Habert, Jeff
    Lessard, Serge
    Alima, Lemore
    Ayas, Najib T.
    Macfarlane, James
    Kendzerska, Tetyana
    Lee, Elliott K.
    Carney, Colleen E.
    SLEEP MEDICINE, 2024, 124 : 598 - 605
  • [35] Management of insomnia in patients with chronic obstructive pulmonary disease
    George, CFP
    Bayliff, CD
    DRUGS, 2003, 63 (04) : 379 - 387
  • [36] Management of chronic insomnia using hypnotics: a friend or a foe?
    Aniruddha Basu
    Tanmay Joshi
    Arghya Pal
    Ravi Gupta
    Sleep and Biological Rhythms, 2022, 20 : 39 - 46
  • [37] Clinical Guideline for the Evaluation and Management of Chronic Insomnia in Adults
    Schutte-Rodin, Sharon
    Broch, Lauren
    Buysse, Daniel
    Dorsey, Cynthia
    Sateia, Michael
    JOURNAL OF CLINICAL SLEEP MEDICINE, 2008, 4 (05): : 487 - 504
  • [38] Management of chronic insomnia using hypnotics: a friend or a foe?
    Basu, Aniruddha
    Joshi, Tanmay
    Pal, Arghya
    Gupta, Ravi
    SLEEP AND BIOLOGICAL RHYTHMS, 2022, 20 (01) : 39 - 46
  • [39] Inflammatory bowel diseases, chronic liver diseases and the lung
    Rodriguez-Roisin, Roberto
    Bartolome, Sonja D.
    Huchon, Gerard
    Krowka, Michael J.
    EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (02) : 638 - 650
  • [40] An update of management of insomnia in patients with chronic orofacial pain
    Almoznino, G.
    Haviv, Y.
    Sharav, Y.
    Benoliel, R.
    ORAL DISEASES, 2017, 23 (08) : 1043 - 1051